|
|
||||||||
Letters to the Editor |
1 Department of Hematology, Leyenburg Hospital, The Hague, The Netherlands
2 Departments of Endocrinology and Epidemiology, and Biostatistics and6
Laboratory of Pediatrics and Neurology, University Medical Center Nijmegen, Nijmegen, The Netherlands
3 Laboratory of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands
4 Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands
5 Department of Internal Medicine, University Hospital Maastricht, Maastricht, The Netherlands
aAddress correspondence to this author at: Department of Internal Medicine, Máxima Medical Center Eindhoven, PO Box 90052, 5600 PD Eindhoven, The Netherlands. Fax 31-40-245-0385; e-mail hpj.willems{at}niv.medonline.nl.
To the Editor:
Blood collection for total homocysteine (tHcy) measurements is usually done in tubes containing EDTA as anticoagulant. At room temperature there is an increase in tHcy in whole blood (1)(2); therefore, tubes must be put on melting ice immediately and centrifuged within 1 or 2 h. Large epidemiologic studies, however, require blood collection techniques that are easily applicable in a field setting. We found that citrate with a low pH (pH 4.3; pH
5.9 after mixing with blood) stabilizes tHcy in whole blood for 6 h when the blood is stored at room temperature (1), but that measured absolute tHcy concentrations differ in acidic citrate and EDTA.
In this study we investigated the differences between measured tHcy concentrations in EDTA- and acidic citrate-anticoagulated blood obtained with different measurement methods. Blood was collected from 208 volunteers (79 males and 129 females; age range, 2388 years; median age, 65 years) in tubes containing EDTA (Vacutainer®; Becton Dickinson) and tubes containing acidic citrate (Stabilyte®; Biopool) as anticoagulant. The EDTA tubes were stored at 0 °C immediately after blood sampling until processing, whereas the acidic citrate tubes were kept at room temperature. tHcy was measured with three different methods:
As shown in Table 1
, there were differences between mean tHcy concentrations measured in acidic citrate and EDTA plasma, but tHcy in acidic citrate and EDTA correlated highly regardless of the measurement method used. We hypothesized that the differences found could be the result of the acidic environment interacting with the measurement. We acidified EDTA plasma by adding HCl and did 10 additional measurements with the HPLC(a) method, but measured tHcy concentrations in the regular EDTA plasma and the acidic EDTA plasma were comparable (data not shown). It may be that acidic citrate itself either inhibits derivatization with ammonium-7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonate, causing the tHcy to be lower with the HPLC(b) method, or causes some interference with the HPLC(a) method, leading to higher measured concentrations in the acidic citrate tubes. This idea is supported by the fact that ammonium-7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonate gives rather "clean" chromatograms, whereas monobromobimane contains spurious material that could generate possible interference.
|
The observed matrix effect is of utmost importance for external calibration of assays for tHcy measurement. Our data highlight the fact that a fluorescent assay for thiols based on derivatization cannot be used with different matrices without validation, which includes recovery experiments and tests for analytical interference.
On the basis of our results, we conclude that tubes containing acidic citrate can be used for homocysteine determination, especially in epidemi-ologic studies, because tHcy corre-lates highly with tHcy in EDTA plasma. However, reference values need to be established for each labo-ratory when either acidic citrate or EDTA is used as anticoagulant.
References
The following articles in journals at HighWire Press have cited this article:
![]() |
U. Hubner, H. Schorr, R. Eckert, J. Geisel, and W. Herrmann Stability of Plasma Homocysteine, S-Adenosylmethionine, and S-Adenosylhomocysteine in EDTA, Acidic Citrate, and PrimavetteTM Collection Tubes Clin. Chem., December 1, 2007; 53(12): 2217 - 2218. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |